OR-RADISYS
25.2.2022 18:02:10 CET | Business Wire | Press release
Radisys® Corporation , a global leader of open telecom solutions, today announced a showcase of its end-to-end open telecom and digital engagement portfolio at MWC Barcelona 2022 in Booth 5B81. Following the successful disaggregation of the flagship Media Server which is currently operating in over 200 networks, Radisys is extending the principles of disaggregation across both fixed and mobile broadband access offerings. Radisys’ Software-centric Network Functions, complemented by Open Hardware components, are now ready for operators to deploy to begin accruing the benefits of modern network architectures. Complementing these offerings, the focus on monetization leverages the power of computing-at-the-edge and offers new revenue opportunities.
Disaggregation of 5G and FTTX Access Networks
- Radisys will demonstrate 5GNR solutions enabled with its Release 16 compliant 5G software and systems integration capabilities. Attendees will learn how Radisys with its ecosystem partners is enabling a diverse customer base in the 5G space for CSPs, private networks and other market verticals. The 5G Innovation Showcase will include a 5G Small Cell demonstration with highly optimized architecture and low footprint and a network-in-a-box demonstration with 5G vRAN protocol software.
- Radisys will demonstrate its open, disaggregated, cloud native PON solution with the flexibility and scalability to transform FTTX networks. Attendees will see triple-play services over XGS-PON with Radisys’ Combo PON OLTs (simultaneous G-PON and XGS-PON support).
- Radisys is actively participating in the SD-RAN and VOLTHA demonstrations with ONF. Meet Radisys at the ONF Pavilion Hall 1 (Booth 1F66).
Broadband-everywhere
- Radisys will demonstrate the realization of true, converged broadband-everywhere networks powered by software-defined, disaggregated, Open RAN leveraging FTTX-based xHaul transport supported by automation, analytics monetization, and guaranteed assurance of service.
- Radisys will showcase its complete network lifecycle services – consult, design, build, integrate, operate, and optimize – across all of the network domains of today’s digital networks including the RAN, Optical/IP Transport, Core and Enterprise networks.
Monetization
- Radisys’ Smart Living Demonstration is made possible by Radisys’ Reach Smart Home that enables broadband service providers to increase customer stickiness and revenue by bundling smart home services with broadband plans. Use cases include comfort living, home security, safety and energy management. Radisys’ Smart Home Operator Dashboard brings insightful business KPIs for monetizing new services.
-
Radisys’ Digital Engagement showcase will highlight the video analytics capabilities of its Engage Platform, including mask detection and social distancing. Service providers can use these analytics to build specific applications such as biometric authentication and COVID policy enforcement.
- Attendees will have a personalized interaction with Radisys’ Engage Video Assistant (EVA) – the world’s first three-in-one AI-based video bot.
- Radisys will feature its newly launched Engage Digital Platform (EDP), a flexible, reliable and low code/no code Communications Platform-as-a-Service (CPaaS). Radisys will demonstrate the ease of use of the EDP Portal where admins and developers can create new services almost instantaneously via a drag and drop menu.
Leadership Presence
- Radisys and global service providers Deutsche Telekom and Reliance Jio will share their joint vision on disaggregated access during an interactive panel discussion taking place Tuesday, March 1 at 15:10-15:25 CET on the DT booth stage, Booth 3M31.
- Radisys is sponsoring the Open RAN Summit at MWC. Ganesh Shenbagaraman, head of integrated products and ecosystems, will participate on a panel discussion on “Open RAN Opportunity Use Cases” on March 2 from 2:30pm-3:30pm in CC3.13 Fira Gran Via.
- Radisys’ head of Mobility Software and Services, Munish Chhabra will participate in Xilinx’s 5G Leadership Power Hour Theater Session on March 2 from 9:30am-11:00am at the CET Theater 2 in Hall 7.
“Our theme for MWC is ‘Connectivity Reimagined, Experience Reimagined, Telco Reimagined’ and we are showing service provider and enterprise customers how our solutions can aid their network and business transformation with open platforms and architectures, and new innovative services and digital engagement solutions to reimagine their role as true digital engagement providers,” said Natasha Tamaskar, head of Global Marketing, Business Strategy and Digital Endpoints Business, Radisys. “Unlike other modern OEMs in the market, Radisys has a unique position as our portfolio covers both fixed and mobile access and leverages the global footprint of our media platform complemented by digital endpoints and services. Our solutions enable greater service opportunities and enhanced digital experiences for customers across the globe.”
To meet with Radisys’ experts at MWC Barcelona and learn more about innovations in Open RAN, broadband, and digital engagement, contact open@radisys.com .
About Radisys
Radisys, a global leader in open telecom solutions, enables service providers to drive disruption with new open architecture business models. Radisys’ innovative disaggregated and virtualized enabling technology solutions leverage open reference architectures and standards, combined with open software and hardware to power business transformation for the telecom industry, while its world-class services organization delivers systems integration expertise necessary to solve communications’ and content providers’ complex deployment challenges. For more information, visit www.Radisys.com .
Radisys® is a registered trademark of Radisys. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220225005400/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
